MAGNANI, ELIANA
 Distribuzione geografica
Continente #
NA - Nord America 425
EU - Europa 271
AS - Asia 109
Totale 805
Nazione #
US - Stati Uniti d'America 423
PL - Polonia 128
IE - Irlanda 53
CN - Cina 41
IT - Italia 36
HK - Hong Kong 28
SE - Svezia 28
JO - Giordania 19
SA - Arabia Saudita 15
GB - Regno Unito 6
DE - Germania 5
RU - Federazione Russa 5
UA - Ucraina 3
BE - Belgio 2
CA - Canada 2
CH - Svizzera 2
ES - Italia 2
IN - India 2
KR - Corea 2
SG - Singapore 2
FI - Finlandia 1
Totale 805
Città #
Warsaw 128
Fairfield 67
Chandler 57
Dublin 53
Beijing 26
Seattle 26
Houston 25
Cambridge 21
Lawrence 21
Woodbridge 21
Ashburn 20
Hong Kong 20
Altamura 19
Wilmington 19
Ann Arbor 16
Princeton 13
Riyadh 13
New York 12
Buffalo 10
Kent 9
Boston 7
Dearborn 7
Shanghai 7
Medford 5
Moscow 5
Florence 4
London 4
Norwalk 4
Genoa 3
San Diego 3
Barcelona 2
Bern 2
Bremen 2
Brussels 2
Buraidah 2
Faenza 2
Falls Church 2
Forlì 2
Hefei 2
Seoul 2
Singapore 2
Toronto 2
Bielefeld 1
Foggia 1
Fuzhou 1
Hanover 1
Hebei 1
Hyderabad 1
Kunming 1
Milan 1
Mumbai 1
Nanjing 1
Phoenix 1
Pontassieve 1
Portland 1
Redwood City 1
Reggio Calabria 1
Wenzhou 1
Ürümqi 1
Totale 686
Nome #
Markers of JC virus infection in patients with multiple sclerosis under natalizumab therapy. 217
Safety and efficacy of autologous hematopoietic stem cell transplantation following natalizumab discontinuation in aggressive Multiple Sclerosis. 103
Severe disease reactivation in two multiple sclerosis patients after natalizumab withdrawal was not halted by monthly administrations of cyclophosphamide - two case reports 68
Differentiation by MRI between multiple sclerosis and MS-like syndromes with markers of "better explanation" of the diagnosis. 61
The diagnosis of multiple sclerosis with markers of "better explanation": accuracy of the "central vein sign" in uncovering pathogenic mechansms different from inflammatory demyelination 61
Accuracy of the central vein sign evaluation by brain MRI for the pathologic characterization of multiple sclerosis cases with markers of "better explanation" of the diagnosis. 56
Association of celiac disease in patients with multiple sclerosis in Tuscany 56
MRI evaluation of the "central vein sign" in brain white matter lesions of multiple sclerosis and systemic autoimmune diseases. 53
Real Life comparative evaluation of dimethyl fumarate efficacy and tolerability in relapsing remitting multiple sclerosis patients switching from other treatments 41
Leptomeningeal enhancement analysis in diagnostic clinical setting 41
Comparative long term efficacy of beta interferons and azathioprine in relapsing-remitting Multiple sclerosis: single center retrospective 25 year evaluation 38
Evaluation of dimethyl fumarate efficacy and safety in patients with relapsing remitting multiple sclerosis switching from other treatments 34
Totale 829
Categoria #
all - tutte 2.767
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.767


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201911 0 0 0 0 0 0 0 0 0 0 0 11
2019/2020176 7 3 7 19 17 7 20 23 27 26 18 2
2020/202189 8 6 3 14 9 14 4 7 8 10 3 3
2021/202284 1 7 5 6 2 7 6 6 2 5 11 26
2022/2023255 20 47 19 6 20 44 34 14 43 1 4 3
2023/2024108 2 10 13 9 8 10 4 23 1 2 16 10
Totale 829